1-8 of 8
Shaloo Gupta
Close
Sort by
Journal Articles

Time and Side-Effect Burden Associated with Red Blood Cell Transfusions in Patients Diagnosed with Transfusion-Dependent β-Thalassemia

Shaloo Gupta, Halley Costantino, Kacper Perkowski, Bryan Inyart, Lauren Ashka, Kelly Clapp, Kwanza Price, Russell L. Knoth
Journal: Blood
Blood (2021) 138 (Supplement 1): 4987.
https://doi.org/10.1182/blood-2021-145875
Published: 2021
Journal Articles

Understanding the Association between Red Blood Cell Transfusion Dependency and Humanistic, Psychosocial, and Psychological Burden in Patients with β-Thalassemia from the Patients' Perspective

Kwanza Price, Shaloo Gupta, Kacper Perkowski, Halley Costantino, Bryan Inyart, Lauren Ashka, Kelly Clapp, Russell L. Knoth
Journal: Blood
Blood (2021) 138 (Supplement 1): 4062.
https://doi.org/10.1182/blood-2021-145302
Published: 2021
Journal Articles

Association between Transfusion Status (TS) and Clinical and Economic Outcomes in Patients with Myelodysplastic Syndromes (MDS) from the Physicians' Perspective

Austin Kulasekararaj, MDMBBS,MRCP,FRCPath, Shaloo Gupta, Thomas Schroeder, Halley Constantino, Jay Grisolano, Jackson Tang, Shalon Jones, Derek Tang
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-136740
Published: 2020
Journal Articles

Physicians' Experience in Blood Supply Shortages and the Top Factors That Impact the Clinical, Economic, and Humanistic Outcomes of Myelodysplastic Syndrome (MDS) Patients in 5 European Countries

Shaloo Gupta, Thomas Schroeder, Austin Kulasekararaj, MDMBBS,MRCP,FRCPath, Halley Constantino, Jay Grisolano, Jackson Tang, Shalon Jones, Derek Tang
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-136698
Published: 2020
Journal Articles

Understanding the Association between Transfusion Status (TS) and Overall Survival (OS), and Other Clinical Outcomes in Patients with Myelodysplastic Syndromes (MDS) from the Physicians' Perspective: A Pilot Survey

Shaloo Gupta, Zhiyi Li, Thomas Schroeder, MD, Austin Kulasekararaj, MDMBBS,MRCP,FRCPath, Joana E. Matos, Alexandra Berk, Derek Tang, PhD BSPharm, Jay Grisolano
Journal: Blood
Blood (2019) 134 (Supplement_1): 5901.
https://doi.org/10.1182/blood-2019-122725
Published: 2019
Journal Articles

Rationale for Therapy Discontinuation in Patients with Lower-Risk Transfusion-Dependent Myelodysplastic Syndromes (MDS)

Aaron T. Gerds, MD MS, Shaloo Gupta, MS, Gary Binder, MBA, Mikkael A. Sekeres, MD MS, Aziz Nazha, MD, Hetty E. Carraway, MD MBA, Stephanie Hawthorne, PhD, Kristen King-Concialdi, BS, Michael McGuire, PharmD
Journal: Blood
Blood (2016) 128 (22): 3541.
https://doi.org/10.1182/blood.V128.22.3541.3541
Published: 2016
Journal Articles

Assessing the Effect of Injectable or Oral Routes of Treatment Administration on Patient-Reported Outcomes and out-of-Pocket Costs Among Patients with Multiple Myeloma

Shaloo Gupta, MS, Safiya Abouzaid, Ryan Liebert, MS, Kejal Parikh, Aaron S Rosenberg, MD MS
Journal: Blood
Blood (2016) 128 (22): 5931.
https://doi.org/10.1182/blood.V128.22.5931.5931
Published: 2016
Journal Articles

Associations Between Treatment Restrictions, Patient-Reported Treatment Burden and Adherence to Tyrosine-Kinase Inhibitor Therapy Among Chronic Myeloid Leukemia Patients in the United States and Europe

Shaloo Gupta, M.S., Amir Goren, Ph.D., Timothy W Victor, Ph.D., Jonathan Chapnick, Stephanie Hawthorne, PhD, Ishan Hirji, MPH, Eduardo Olavarría, MD, Alyson B Moadel, Ph.D., Colleen Lemoine, APRN, MN, AOCN, RN-BC, Catherine Davis, Pharm.D.
Journal: Blood
Blood (2011) 118 (21): 2077.
https://doi.org/10.1182/blood.V118.21.2077.2077
Published: 2011